Brexpiprazole versus placebo or other antidepressive agents for treating depression
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: <br> To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute‐ and long‐term treatment of major depression.
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Cochrane Collaboration
2021
|